The Original Investigation, “International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer,”1 published online October 3, 2018, was corrected to remove an errant “%” from the sentence “These findings result in an additive NRI of 0.38% and an absolute NRI of 28.6%.” The sentence now reads “These findings result in an additive NRI of 0.38 and an absolute NRI of 28.6%.” In addition, the label on the x-axis of both receiver operating characteristic curves in Figure 2 has been corrected to “1 − Specificity,” instead of “Specificity.”
1.van Roessel
S, Kasumova
GG, Verheij
J,
et al. International validation of the eighth edition of the American Joint Committee on Cancer (AJCC) TNM staging system in patients with resected pancreatic cancer [published online October 3, 2018].
JAMA Surg. 2018;153(12):e183617. doi:
10.1001/jamasurg.2018.3617PubMedGoogle ScholarCrossref